Role of Wdr13 Gene in Beta Cell Proliferation Table S1 (DOC) Table S3 (DOC) Supporting Information Figure S1 Feed consumption (gram/day) by knockout mice and their wild type littermates. (TIF) Wdr13 Effect of Wdr13 genotype on litter size. Table S2 Weight (in grams) of various organs from Wdr13 mutant and their wild type littermates at 12 months. (DOC) siRNA knockdown of WDR13 in MIN6 cells MIN6 cells were transfected with non-specific scrambled (Scr) siRNA (Sc-37007) and Wdr13-specific siRNA (Sc-155258-Santa- cruz) using lipofectamin TM2000 (Invitrogen) in 30 mm dish (100 pmole each). The cells were lysed after 72 h post transfection and analyzed by immunoblotting. Chromatin immunoprecipitation MIN6 cells were transfected with AdGFP and AdWdr13 using 20 MOI and allowed to grow for 48 hours. The cells were crosslinked in 1% formaldehyde for 10 minutes at room temper- ature and scraped in PBS containing protease inhibitors. Chromatin immunoprecipitation was performed using the chro- matin immunoprecipitation (ChIP) Assay Kit, Millipore (Cata- logue Number: 17–295) as per the manufacturer’s instructions. Briefly, cell lysate was precleaned by incubating in agarose beads for 1 h at room temperature followed by immunoprecipitation with anti-FLAG agarose beads for 3 h. The beads were washed and the genomic DNA fragments were eluted for identification of various promoter regions by PCR (Table S3). The experiments were repeated two times. Statistical analysis The unpaired two-tailed t test was used for statistical analysis. Microsoft Excel software was used for calculation of P values. A P value,0.05 was considered significant. Data are presented as mean 6 SEM. References 1. Smith TF, Gaitatzes C, Saxena K, Neer EJ (1999) The WD repeat: a common architecture for diverse functions. Trends Biochem Sci 24: 181–185. 2. Smith TF (2008) Diversity of WD-repeat proteins. Subcell Biochem 48: 20–30. 3. Singh BN, Suresh A, UmaPrasad G, Subramanian S, Sultana M, et al. (2003) A highly conserved human gene encoding a novel member of WD-repeat family of proteins (WDR13). Genomics 81: 315–328. 4. Whibley AC, Plagnol V, Tarpey PS, Abidi F, Fullston T, et al. (2010) Fine-scale survey of X chromosome copy number variants and indels underlying intellectual disability. Am J Hum Genet 87: 173–188. 5. El-Hattab A, Bournat J, Eng PA, Wu JB, Walker BA, et al. (2010) Microduplication of Xp11.23p11.3 with effects on cognition, behavior, and craniofacial development. Clin Genet. 6. D’Agata V, Schreurs BG, Pascale A, Zohar O, Cavallaro S (2003) Down regulation of cerebellar memory related gene-1 following classical conditioning. Genes Brain Behav 2: 231–237. 7. Price M, Lang MG, Frank AT, Goetting-Minesky MP, Patel SP, et al. (2003) Seven cDNAs enriched following hippocampal lesion: possible roles in neuronal responses to injury. Brain Res Mol Brain Res 117: 58–67. 8. Suresh A, Shah V, Rani DS, Singh BN, Prasad GU, et al. (2005) A mouse gene encoding a novel member of the WD family of proteins is highly conserved and predominantly expressed in the testis (Wdr13). Mol Reprod Dev 72: 299–310. 9. Podcheko A, Northcott P, Bikopoulos G, Lee A, Bommareddi SR, et al. (2007) Identification of a WD40 repeat-containing isoform of PHIP as a novel regulator of beta-cell growth and survival. Mol Cell Biol 27: 6484–6496. 10. Honore B, Baandrup U, Nielsen S, Vorum H (2002) Endonuclein is a cell cycle regulated WD-repeat protein that is up-regulated in adenocarcinoma of the pancreas. Oncogene 21: 1123–1129. 11. Finegood DT, Scaglia L, Bonner-Weir S (1995) Dynamics of beta-cell mass in the growing rat pancreas. Estimation with a simple mathematical model. Diabetes 44: 249–256. 12. Bouwens L, Rooman I (2005) Regulation of pancreatic beta-cell mass. Physiol Rev 85: 1255–1270. 13. Bonner-Weir S (2000) Perspective: Postnatal pancreatic beta cell growth. Endocrinology 141: 1926–1929. 14. Dor Y, Brown J, Martinez OI, Melton DA (2004) Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature 429: 41– 46. 15. Thorel F, Nepote V, Avril I, Kohno K, Desgraz R, et al. (2010) Conversion of adult pancreatic alpha-cells to beta-cells after extreme beta-cell loss. Nature 464: 1149–1154. 16. Heit JJ, Karnik SK, Kim SK (2006) Intrinsic regulators of pancreatic beta-cell proliferation. Annu Rev Cell Dev Biol 22: 311–338. 17. Mauvais-Jarvis F (2011) Estrogen and androgen receptors: regulators of fuel homeostasis and emerging targets for diabetes and obesity. Trends Endocrinol Metab 22: 24–33. PLoS ONE | www.plosone.org 9 June 2012 | Volume 7 | Issue 6 | e38685 List of primers. Acknowledgments We thank Lalji for support, Nandini for assistance in microscopy, Anand for help in adenovirus vector construction, Bert Vogelstein for providing pAd Easy system, Chandrasekharan and Ramakrishna Murti for discus- sions. Author Contributions Conceived and designed the experiments: VPS SK. Performed the experiments: SS BJL SG VS DPS VPS SK. Analyzed the data: VPS SK. Wrote the paper: VPS SK. 18. Rhodes CJ (2005) Type 2 diabetes-a matter of beta-cell life and death? Science 307: 380–384. 19. Lustig RH, Sen S, Soberman JE, Velasquez-Mieyer PA (2004) Obesity, leptin resistance, and the effects of insulin reduction. Int J Obes Relat Metab Disord 28: 1344–1348. 20. Rohner-Jeanrenaud F, Jeanrenaud B (1985) Involvement of the cholinergic system in insulin and glucagon oversecretion of genetic preobesity. Endocrinol- ogy 116: 830–834. 21. Muoio DM, Newgard CB (2008) Mechanisms of disease: molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes. Nat Rev Mol Cell Biol 9: 193–205. 22. Hanley SC, Austin E, Assouline-Thomas B, Kapeluto J, Blaichman J, et al. (2010) {beta}-Cell mass dynamics and islet cell plasticity in human type 2 diabetes. Endocrinology 151: 1462–1472. 23. Ritzel RA, Butler AE, Rizza RA, Veldhuis JD, Butler PC (2006) Relationship between beta-cell mass and fasting blood glucose concentration in humans. Diabetes Care 29: 717–718. 24. Willing AE, Walls EK, Koopmans HS (1990) Insulin infusion stimulates daily food intake and body weight gain in diabetic rats. Physiol Behav 48: 893–898. 25. Song B, Scheuner D, Ron D, Pennathur S, Kaufman RJ (2008) Chop deletion reduces oxidative stress, improves beta cell function, and promotes cell survival in multiple mouse models of diabetes. J Clin Invest 118: 3378–3389. 26. Wen T, Peng B, Pintar JE (2009) The MOR-1 opioid receptor regulates glucose homeostasis by modulating insulin secretion. Mol Endocrinol 23: 671–678. 27. Girard J, Perdereau D, Foufelle F, Prip-Buus C, Ferre P (1994) Regulation of lipogenic enzyme gene expression by nutrients and hormones. FASEB J 8: 36– 42. 28. Bluher M, Michael MD, Peroni OD, Ueki K, Carter N, et al. (2002) Adipose tissue selective insulin receptor knockout protects against obesity and obesity- related glucose intolerance. Dev Cell 3: 25–38. 29. Bruning JC, Michael MD, Winnay JN, Hayashi T, Horsch D, et al. (1998) A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol Cell 2: 559–569. 30. Loftus TM, Kuhajda FP, Lane MD (1998) Insulin depletion leads to adipose- specific cell death in obese but not lean mice. Proc Natl Acad Sci U S A 95: 14168–14172. 31. Ariyama Y, Shimizu H, Satoh T, Tsuchiya T, Okada S, et al. (2007) Chop- deficient mice showed increased adiposity but no glucose intolerance. Obesity (Silver Spring) 15: 1647–1656. 32. Lee YC, Nielsen JH (2009) Regulation of beta cell replication. Mol Cell Endocrinol 297: 18–27. 33. Gerich JE (1998) The genetic basis of type 2 diabetes mellitus: impaired insulin secretion versus impaired insulin sensitivity. Endocr Rev 19: 491–503. 34. Rosen ED, Spiegelman BM (2000) Molecular regulation of adipogenesis. Annu Rev Cell Dev Biol 16: 145–171.